<SEC-DOCUMENT>0001613103-16-000078.txt : 20160414
<SEC-HEADER>0001613103-16-000078.hdr.sgml : 20160414
<ACCEPTANCE-DATETIME>20160414170614
ACCESSION NUMBER:		0001613103-16-000078
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160414
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160414
DATE AS OF CHANGE:		20160414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Medtronic plc
		CENTRAL INDEX KEY:			0001613103
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0424

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36820
		FILM NUMBER:		161572385

	BUSINESS ADDRESS:	
		STREET 1:		20 ON HATCH, LOWER HATCH STREET
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		01135314381700

	MAIL ADDRESS:	
		STREET 1:		20 ON HATCH, LOWER HATCH STREET
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Ltd
		DATE OF NAME CHANGE:	20150112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Medtronic Holdings Ltd
		DATE OF NAME CHANGE:	20140711

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kalani I Ltd
		DATE OF NAME CHANGE:	20140709
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kxbondtenderxearlyresul.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2016 Workiva -->
		<title>8-K</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s3a5dfa44ca944a45836f37877f349257"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:144%;padding-top:4px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:144%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C.&#160;20549</font></div><div style="line-height:144%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_____________________________</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">_____________________________&#160;</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:144%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of the</font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Securities Exchange Act of 1934</font></div><div style="line-height:144%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Date of Report (Date of Earliest Event Reported):</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;April 14, 2016</font></div><div style="line-height:144%;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">_____________________________</font></div><div style="line-height:144%;padding-top:9px;text-align:center;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;">MEDTRONIC PUBLIC LIMITED COMPANY</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Exact name of Registrant as Specified in its Charter)</font></div><div style="line-height:144%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">_____________________________</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="22%"></td><td width="15%"></td><td width="27%"></td><td width="2%"></td><td width="34%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Ireland</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1-36820</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">98-1183488</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or other jurisdiction</font></div><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">of incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission</font></div><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(IRS Employer</font></div><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:45.1171875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="94%"></td><td width="6%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">20 On Hatch, Lower Hatch Street</font></div><div style="text-align:center;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Dublin 2, Ireland</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:4px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of principal executive offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">+353 1 438-1700</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant&#8217;s telephone number, including area code):</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Not Applicable</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Former Name or Former Address, if Changed Since Last Report) </font></div><div style="line-height:144%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td width="6%"></td><td width="94%"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:174%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s3a5dfa44ca944a45836f37877f349257"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:174%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Item&#160;8.01.  Other Events</font></div><div style="line-height:174%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">On April 14, 2016, Medtronic plc (the &#8220;Company&#8221;) announced the initial results and pricing of its previously announced tender offer by its wholly-owned subsidiaries, Medtronic, Inc. (&#8220;Medtronic, Inc.&#8221;) and Covidien International Finance S.A. (&#8220;CIFSA&#8221;), for up to $3 billion combined aggregate purchase price for certain of Medtronic, Inc.&#8217;s and CIFSA&#8217;s outstanding debt securities.  The tender offer is being made exclusively pursuant to an offer to purchase dated March 31, 2016 and related letter of transmittal, in each case as amended by the press releases attached to this Current Report on Form 8-K, which set forth the terms and conditions of the tender offer.  </font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Copies of the Company&#8217;s press releases announcing the initial results and pricing are attached to this Current Report on Form 8-K as Exhibits 99.1 and 99.2 and are incorporated herein by reference.  The information contained in Item 8.01 of this Current Report on Form 8-K and the press releases attached hereto as Exhibits 99.1 and 99.2 are for information purposes only and do not constitute an offer to purchase the Notes.</font></div><div style="line-height:174%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Item 9.01.  Exhibits</font></div><div style="line-height:120%;padding-bottom:25px;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(d) List of Exhibits</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:89.6484375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="13%"></td><td width="2%"></td><td width="85%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press release of Medtronic plc regarding initial tender offer results, dated April 14, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press release of Medtronic plc regarding pricing of tender offer, dated April 14, 2016</font></div></td></tr></table></div></div><div style="line-height:174%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s3a5dfa44ca944a45836f37877f349257"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.2421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td width="27%"></td><td width="12%"></td><td width="4%"></td><td width="57%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">MEDTRONIC PUBLIC LIMITED COMPANY</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Gary L. Ellis</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: April 14, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gary L. Ellis</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:174%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s3a5dfa44ca944a45836f37877f349257"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;padding-bottom:9px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">EXHIBIT INDEX</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.3984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="10%"></td><td width="5%"></td><td width="85%"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press release of Medtronic plc regarding initial tender offer results, dated April 14, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press release of Medtronic plc regarding pricing of tender offer, dated April 14, 2016</font></div></td></tr></table></div></div><div style="line-height:174%;padding-top:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991-pressreleasexin.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2016 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="s281da84970f340f9af526d81b529dd0c"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="62%"></td><td width="4%"></td><td width="34%"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;"><img src="mdtlogo2a05.jpg" style="height:62px;width:274px;"></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:38px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:38px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NEWS RELEASE</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="51%"></td><td width="3%"></td><td width="18%"></td><td width="3%"></td><td width="25%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contacts:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fernando Vivanco</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ryan Weispfenning</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Public&#160;Relations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investor&#160;Relations</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">+1-763-505-3780</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">+1-763-505-4626</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FOR IMMEDIATE RELEASE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">MEDTRONIC ANNOUNCES THE EARLY RESULTS AND UPSIZING OF ITS CASH TENDER OFFER FOR CERTAIN OUTSTANDING DEBT SECURITIES ISSUED BY MEDTRONIC, INC. AND COVIDIEN INTERNATIONAL FINANCE S.A.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DUBLIN - April 14, 2016 - </font><font style="font-family:inherit;font-size:12pt;">Medtronic plc (the &#8220;Company&#8221;) (NYSE: MDT) today announced that, pursuant to the previously-announced cash tender offer by its wholly-owned subsidiaries, Medtronic, Inc. (&#8220;Medtronic, Inc.&#8221;) and Covidien International Finance S.A. (&#8220;CIFSA&#8221; and, together with Medtronic, Inc., the &#8220;Offerors&#8221;) for the Notes identified in the table below (the &#8220;Notes&#8221;), approximately $5.8 billion in aggregate principal amount of Notes were validly tendered and not validly withdrawn on or prior to 5:00 p.m., New York City time, on April 13, 2016, the Early Tender Deadline for the tender offer (the &#8220;Early Tender Deadline&#8221;). The Company also announced that the Offerors are increasing the &#8220;Maximum Tender Amount&#8221; from $2.75 billion to $3 billion and are amending the &#8220;Tender Caps&#8221; applicable to each series of Notes as further described in the table below. The terms of the tender offer are described in the Offer to Purchase, dated March 31, 2016 (the &#8220;Offer to Purchase&#8221;), and the related Letter of Transmittal, and remain unchanged except as amended hereby.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The following table sets forth certain information regarding the Notes and the tender offer, including the aggregate principal amount of each series of Notes that were validly tendered and not validly withdrawn on or prior to the Early Tender Deadline:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:6pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.1875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td width="19%"></td><td width="9%"></td><td width="14%"></td><td width="10%"></td><td width="16%"></td><td width="14%"></td><td width="18%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Title of Security</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">CUSIP </font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Numbers</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Issuer/Offeror</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Acceptance</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Priority</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Level</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Principal Amount </font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Revised Tender Cap(1)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Principal Amount Tendered</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">6.550% Senior Notes due 2037</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">22303QAH3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">CIFSA</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$850,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$600,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$475,961,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2.950% Senior Notes due 2023</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">22303QAP5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">CIFSA</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$750,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$440,484,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$440,484,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">4.000% Senior Notes due 2043</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055AY2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$750,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$424,976,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$424,976,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2.750% Senior Notes due 2023</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055AZ9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,250,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$719,779,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$719,779,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">4.450% Senior Notes due 2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055AS5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,250,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$484,409,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$484,409,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">4.375% Senior Notes due 2035</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055BT2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$2,500,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">n/a</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,857,239,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2.500% Senior Notes due 2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055BG0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$2,500,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$150,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,415,679,000</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">The Tender Cap for each series represents the maximum aggregate principal amount of Notes of such series that will be purchased in the tender offer.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Because the aggregate consideration payable for validly tendered Notes exceeded the Maximum Tender Amount and, as set forth in the table above, the amount of validly tendered Notes in certain series </font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s281da84970f340f9af526d81b529dd0c"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">exceeded the applicable Tender Cap, the Notes will be purchased subject to the Acceptance Priority Levels and subject to proration as described in the Offer to Purchase and Letter of Transmittal. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The principal amount of each series of Notes listed in the table above ultimately accepted for purchase will depend upon the determination of the Total Consideration (as defined in the Offer to Purchase) at 11:00 a.m., New York City time, on April 14, 2016 and will be determined in accordance with the Maximum Tender Amount, the applicable Tender Caps and the Acceptance Priority Levels set forth in the table above, as described in the Offer to Purchase and Letter of Transmittal, or amended hereby. As a result, a holder who validly tenders Notes pursuant to the Offer may have all or a portion of its Notes returned to it, and the amount of Notes returned will depend on the overall level of participation of holders in the tender offer.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Holders of Notes validly tendered and not validly withdrawn on or prior to the Early Tender Deadline are eligible to receive the Total Consideration, which includes an early tender premium of $30 per $1,000 principal amount of Notes tendered by such holders and accepted for purchase by the Offerors. Accrued interest up to, but not including, the settlement date will be paid in cash on all validly tendered Notes accepted and purchased by the Offerors in the tender offer. The Offerors reserve the right, subject to applicable law, to further increase or waive the Maximum Tender Amount or any applicable Tender Cap. The Company expects to issue a press release after the close of trading on the New York Stock Exchange on April 14, 2016 to announce the Total Consideration payable in connection with the tender offer. The settlement date for the Notes accepted by the Offerors in connection with the Early Tender Deadline is expected to be on April 15, 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Although the tender offer is scheduled to expire at 11:59 p.m., New York City time, on April 27, 2016, because holders of Notes subject to the tender offer validly tendered and did not validly withdraw Notes on or prior to the Early Tender Deadline for which the aggregate consideration payable exceeds the Maximum Tender Amount, the Offerors do not expect to accept for purchase any tenders of Notes after the Early Tender Deadline.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The purpose of the tender offer is to reduce the level of the Company&#8217;s indebtedness, consistent with the capital allocation plans announced by the Company on January 11, 2016. The Company continues to target an A credit profile. The Company expects the costs related to this transaction to be recognized as a one-time expense in its fourth fiscal quarter, and will be excluded from its non-GAAP results. The Company does not expect this transaction to affect its fourth quarter interest expense outlook or its fiscal year 2016 earnings per share guidance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">BofA Merrill Lynch, Citigroup Global Markets, Inc. and J.P. Morgan Securities LLC are acting as the lead dealer managers for the tender offer and HSBC Securities (USA) Inc., Mizuho Securities USA Inc. and Wells Fargo Securities, LLC are acting as co-dealer managers. The information agent and tender agent is Global Bondholder Services Corporation. Copies of the Offer to Purchase, Letter of Transmittal and related offering materials are available by contacting Global Bondholder Services Corporation at (866) 470-4200 (U.S. toll-free) or (212) 430-3774 (banks and brokers). Questions regarding the tender offer should be directed to BofA Merrill Lynch, Liability Management Group, at (980) 387-3907 (collect) or (888) 292-0070 (toll-free); Citigroup Global Markets, Inc., Liability Management Group at (212) 723-6106 (collect) or (800) 558-3745 (toll free) or J.P. Morgan Securities LLC, Liability Management Group, at (212) 834-3424 (collect) or (866) 834-4666 (toll-free). This press release shall not constitute an offer to sell, a solicitation to buy or an offer to purchase or sell any securities. The tender offer is being made only pursuant to the Offer to Purchase and only in such jurisdictions as is permitted under applicable law.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="s281da84970f340f9af526d81b529dd0c"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">About Medtronic</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Medtronic plc (</font><font style="font-family:inherit;font-size:12pt;color:#0000ff;text-decoration:underline;">www.medtronic.com</font><font style="font-family:inherit;font-size:12pt;">), headquartered in Dublin, Ireland, is among the world&#8217;s largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic plc employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">This press release contains forward-looking statements that are not historical in nature. Such forward looking statements are subject to risks and uncertainties, including the risks related to the acceptance of any tendered Notes, the expiration and settlement of the tender offer, the satisfaction of conditions to the tender offer, whether the tender offer will be consummated in accordance with terms set forth in the Offer to Purchase or at all and the timing of any of the foregoing, competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation and general economic conditions and other risks and uncertainties described in the Company&#8217;s periodic reports on file with the U.S. Securities and Exchange Commission including the Annual Report on Form 10-K of the Company, as filed with the U.S. Securities and Exchange Commission. In some cases, you can identify these statements by forward-looking words, such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;looking ahead,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. None of Medtronic plc, Medtronic, Inc. or Covidien International Finance, S.A. undertakes to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances.</font><font style="font-family:inherit;font-size:12pt;">&#32;&#32;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">-end-</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit992-pressreleasexpr.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2016 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<a name="se79e6e4ba24942489521b0f718955c41"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 99.2</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td width="62%"></td><td width="4%"></td><td width="34%"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;"><img src="mdtlogo2a05.jpg" style="height:62px;width:274px;"></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:38px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:38px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NEWS RELEASE</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td width="51%"></td><td width="3%"></td><td width="18%"></td><td width="3%"></td><td width="25%"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Contacts:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fernando Vivanco</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ryan Weispfenning</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Public&#160;Relations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investor&#160;Relations</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">+1-763-505-3780</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">+1-763-505-4626</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FOR IMMEDIATE RELEASE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">MEDTRONIC ANNOUNCES THE PRICING TERMS OF ITS CASH TENDER OFFER OF CERTAIN OUTSTANDING DEBT SECURITIES ISSUED BY MEDTRONIC, INC. AND COVIDIEN INTERNATIONAL FINANCE S.A.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">DUBLIN - April 14, 2016 - </font><font style="font-family:inherit;font-size:12pt;">Medtronic plc (the &#8220;Company&#8221;) (NYSE: MDT) today announced the pricing terms of the previously-announced cash tender offer by its wholly-owned subsidiaries, Medtronic, Inc. (&#8220;Medtronic, Inc.&#8221;) and Covidien International Finance S.A. (&#8220;CIFSA&#8221; and, together with Medtronic, Inc., the &#8220;Offerors&#8221;), for up to $3 billion combined aggregate purchase price (excluding accrued and unpaid interest to, but not including, the applicable settlement date and excluding fees and expenses related to the tender offer) (the &#8220;Maximum Tender Amount&#8221;) of certain of CIFSA&#8217;s and Medtronic, Inc.&#8217;s notes listed in the table below (collectively, the &#8220;Notes&#8221;), an increase from $2.75 billion as set forth in the Offer to Purchase, dated March 31, 2016. The terms of the tender offer are described in the Offer to Purchase and the related Letter of Transmittal, and remain unchanged except as amended hereby and by the Company&#8217;s press release earlier today. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Total Consideration for each series of Notes is based on the applicable reference yield plus a fixed spread, in each case as set forth in the table below, and is payable to holders of the Notes who validly tendered and did not validly withdraw their Notes on or before 5:00 p.m., New York City time, on April 13, 2016 (the &#8220;Early Tender Deadline&#8221;) and whose Notes are accepted for purchase by the Offerors. The Reference Yields listed in the table were determined at 11:00 a.m., New York City time, on April 14, 2016 by the lead dealer managers (identified below). The Total Consideration for each series of Notes includes an early tender premium of $30 per $1,000 principal amount of Notes validly tendered and not validly withdrawn by such holders and accepted for purchase by the Offerors.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="se79e6e4ba24942489521b0f718955c41"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:center;font-size:6pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.3828125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td width="8%"></td><td width="9%"></td><td width="8%"></td><td width="10%"></td><td width="11%"></td><td width="8%"></td><td width="10%"></td><td width="11%"></td><td width="11%"></td><td width="14%"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Title of Security</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">CUSIP </font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Numbers</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Issuer/</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Offeror</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Acceptance</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Priority</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Level</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Reference U.S. Treasury Security</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Reference Yield</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">Fixed Spread</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">(basis points)</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:Arial;font-size:6pt;font-weight:bold;">(1)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Total Consideration (2)(3)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Revised Tender Cap</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Principal Amount Accepted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">6.550% Senior Notes due 2037</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">22303QAH3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">CIFSA</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">3.000% U.S. Treasury Notes due 11/15/2045</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2.592%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">130</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,384.77</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$600,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$475,961,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2.950% Senior Notes due 2023</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">22303QAP5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">CIFSA</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1.625% U.S. Treasury Notes due 02/15/2026</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1.785%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,048.86</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$440,484,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$440,484,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">4.000% Senior Notes due 2043</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055AY2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">3.000% U.S. Treasury Notes due 11/15/2045</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2.592%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,069.29</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$424,976,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$424,976,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2.750% Senior Notes due 2023</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055AZ9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1.625% U.S. Treasury Notes due 02/15/2026</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1.785%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,044.65</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$719,779,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$719,779,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">4.450% Senior Notes due 2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055AS5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1.250% U.S. Treasury Notes due 03/31/2021</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1.237%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">20</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,114.34</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$484,409,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$484,409,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">4.375% Senior Notes due 2035</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055BT2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">3.000% U.S. Treasury Notes due 11/15/2045</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2.592%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">90</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,121.47</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">n/a</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$118,381,000</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">2.500% Senior Notes due 2020</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">585055BG0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">Medtronic, Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1.250% U.S. Treasury Notes due 03/31/2021</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">1.237%</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$1,038.40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">$150,000,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">n/a</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Inclusive of the early tender premium.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Per $1,000 principal amount of Notes that are tendered and accepted for purchase.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">The Total Consideration includes the early tender premium of $30 per $1,000 principal amount of Notes.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Offerors have accepted for purchase Notes validly tendered and not validly withdrawn on or before the Early Tender Deadline for which the aggregate principal amount of the applicable series of Notes did not exceed the applicable Tender Cap as set forth in the table above and for which the aggregate consideration payable did not exceed the Maximum Tender Amount. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Notes not accepted for purchase will be promptly credited to the account of the registered holder of such Notes with The Depository Trust Company or otherwise returned in accordance with the Offer to Purchase and Letter of Transmittal.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">All payments for Notes purchased in connection with the Early Tender Deadline will also include accrued and unpaid interest on the principal amount of Notes tendered up to, but not including, the early settlement date, which is currently expected to be April 15, 2016. In accordance with the terms of the tender offer, the withdrawal deadline was 5:00 p.m., New York City time, on April 13, 2016. As a result, tendered Notes may no longer be withdrawn, except in certain limited circumstances where additional withdrawal rights are required by law (as determined by the Offerors). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Although the tender offer is scheduled to expire at 11:59 p.m., New York City time, on April 27, 2016, because holders of Notes subject to the tender offer validly tendered and did not validly withdraw Notes on or prior to the Early Tender Deadline for which the aggregate consideration payable exceeds the Maximum Tender Amount, the Offerors do not expect to accept for purchase any tenders of Notes after the Early Tender Deadline.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The purpose of the tender offer is to reduce the level of the Company&#8217;s indebtedness, consistent with the capital allocation plans announced by the Company on January 11, 2016. The Company continues to target an A credit profile. The Company expects the costs related to this transaction to be recognized as a one-time expense in its fourth fiscal quarter, and will be excluded from its non-GAAP results. The Company does not expect this transaction to affect its fourth quarter interest expense outlook or its fiscal year 2016 earnings per share guidance.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><a name="se79e6e4ba24942489521b0f718955c41"></a><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><br><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">BofA Merrill Lynch, Citigroup Global Markets, Inc. and J.P. Morgan Securities LLC are acting as the lead dealer managers for the tender offer and HSBC Securities (USA) Inc., Mizuho Securities USA Inc. and Wells Fargo Securities, LLC are acting as co-dealer managers. The information agent and tender agent is Global Bondholder Services Corporation. Copies of the Offer to Purchase, Letter of Transmittal and related offering materials are available by contacting Global Bondholder Services Corporation at (866) 470-4200 (U.S. toll-free) or (212) 430-3774 (banks and brokers). Questions regarding the tender offer should be directed to BofA Merrill Lynch, Liability Management Group, at (980) 387-3907 (collect) or (888) 292-0070 (toll-free); Citigroup Global Markets, Inc., Liability Management Group at (212) 723-6106 (collect) or (800) 558-3745 (toll free) or J.P. Morgan Securities LLC, Liability Management Group, at (212) 834-3424 (collect) or (866) 834-4666 (toll-free). This press release shall not constitute an offer to sell, a solicitation to buy or an offer to purchase or sell any securities. The tender offer is being made only pursuant to the Offer to Purchase and only in such jurisdictions as is permitted under applicable law.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">About Medtronic</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Medtronic plc (</font><font style="font-family:inherit;font-size:12pt;color:#0000ff;text-decoration:underline;">www.medtronic.com</font><font style="font-family:inherit;font-size:12pt;">), headquartered in Dublin, Ireland, is among the world&#8217;s largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic plc employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">This press release contains forward-looking statements that are not historical in nature. Such forward looking statements are subject to risks and uncertainties, including the risks related to the acceptance of any tendered Notes, the expiration and settlement of the tender offer, the satisfaction of conditions to the tender offer, whether the tender offer will be consummated in accordance with terms set forth in the Offer to Purchase or at all and the timing of any of the foregoing, competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation and general economic conditions and other risks and uncertainties described in the Company&#8217;s periodic reports on file with the U.S. Securities and Exchange Commission including the Annual Report on Form 10-K of the Company, as filed with the U.S. Securities and Exchange Commission. In some cases, you can identify these statements by forward-looking words, such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;looking ahead,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. None of Medtronic plc, Medtronic, Inc. or Covidien International Finance, S.A. undertakes to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">-end-</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><br><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>mdtlogo2a05.jpg
<TEXT>
begin 644 mdtlogo2a05.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
MM1$  @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!
M"2,S4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=8
M65IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ
M_]H # ,!  (1 Q$ /P#]_**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH ***BNBRQ?*0#G\_:DP):*_&SQ'_ ,'3NO:#XAOK-?@W
MI,JVD[PHS>(Y09%5F ; MN,@#\ZI_P#$5KX@_P"B+:/_ .%'-_\ (U?6K@C.
M&KJFO_ H_P"9\F^-LH3LZC_\!E_D?L_17XP?\16OB#_HBVC_ /A1S?\ R-1_
MQ%:^(/\ HBVC_P#A1S?_ "-3_P!1\X_Y]K_P*/\ F+_7?)_^?C_\!E_D?L_1
M7XOG_@ZS\0MP/@KI)/MXDFS_ .DU?67_  27_P""RDO_  4G^)?BSPQJ/@ZS
M\(WV@Z;'JEJ(=4:\^V1^;Y4N0T:;=I>+_ONN3&\*9GA:,J]>G:,=_>3_ "9U
MX+BO+,56C0HU+REMHU^A]W44@.2>:6OG3Z(**** "BF3,54$9Z^F:^&O^"M'
M_!8>7_@FGXX\'Z%IOA"S\97OB2RN+ZZCN-2:T^Q1HZ1Q$;8W+;V$W4?\L^O:
MNS 8"OC*RP^'5Y/IML<>/Q]#!T77Q#M%?J?=%%?C!_Q%:^(/^B+:/_X4<W_R
M-1_Q%:^(/^B+:/\ ^%'-_P#(U?0_ZCYQ_P ^U_X%'_,^>_UWR?\ Y^/_ ,!E
M_D?L_17XP?\ $5KX@_Z(MH__ (4<W_R-1_Q%:^(/^B+:/_X4<W_R-1_J/G'_
M #[7_@4?\P_UWR?_ )^/_P !E_D?L_17XS:=_P '5FMW>H01S_!S2K>W:51+
M*OB&5C&A8!F ^S\X!Z5^R=LS,%+9^9<]<X]O\BO(S3),9EW+];CR\U[:I[6[
M>IZV5YY@\PYOJDK\MKZ-;W[^A-1117DGKA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%,G!*8!()^M?%G_  5P_P""K>I?
M\$QI? !LO!=KXO'C;^T=XN-2>T%I]E^RXQMC?=N^T'_OFNK X*MC*\<-AU>3
MVUMLK]3CQV.HX.B\1B':*WTONTOU/M:BOQ@_XBM?$'_1%M'_ /"CF_\ D:C_
M (BM?$'_ $1;1_\ PHYO_D:OH_\ 4?./^?:_\"C_ )GSW^N^3_\ /Q_^ R_R
M/V?HK\GOV5O^#DG7/VD?VD? _@*7X3Z7I,7B[6;;2GO$UZ65K82R!-X4P '&
M>F17ZO0L'4$'(QUSG->)F>48K+YQIXN-G)76J>GR/:RS.,+F$'4PLKI.ST:U
MWZCZ***\T],**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HJ.X8JF<[1GD^@K\U/^"@W_!Q=X2_9P\3W_A+X6:1;?$/Q
M%I[M#>:I/<F+1K&4<%$9/GN64C#;611V<G('?EV5XK'U?8X6',_P7J^AY^8Y
MKA<#3]KBI<J_%^BZGZ7T5_/ZG_!S)^T8-:-W]D^'+P'_ )<O[%G\@#(Z'[0)
M/_'^]?;O_!/7_@X>\(_M0>+]-\&?$C1X?A_XLU1_)L;^"Y,VCZC+QB/<V'@D
M;G:'#(<8WY*@^YCN"\UPM)UI04DM^5W:^1XF"XSRO$U51C-Q;VYE9/Y_YGZ2
MT5% Y9N2#WX/TJ6OE#ZNX4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 51\3ZHNB>';Z]892SMY)V&<9"H6_I5ZN$_:CUG_ (1S]FCXAZ@2
MRBP\,ZE<$J<,-EK*W'OQ6E*'-4C'NU^9E7ERTY2[)G\E[NTCLS$DL=S9.3D\
MG)[GGK24 YC4 8'8=P..**_J:&B/Y=EJ[A1115""OLS_ ((&?&(_"3_@IGX*
M@DF$-CXO@N_#UR2V,^=$9(1]3<0P#\J^,ZZGX'?$VY^"OQG\)>,;//VGPKK-
MGJ\8!P6:"=)0/QVX/MFN'-,+]9P=6@_M1:_#0[LLQ/U?%TJZ^S)/\3^N"+/K
M3ZI:%JMOKVEVU_9RI<6E["D\$J<K(C ,K#V((-7:_F)JSLS^F(M-704444BA
M'&1].:_G-_X.#?C!_P +6_X*9^*;..59K7P7I]EX>@93D I&;B5?PFN9!]0:
M_HKU:^ATS3IKFXE6""W1I9)&.%15!))/H #7\EG[1/Q5G^.?Q]\:^,[@MYOB
MO7;W5BK,3L$]P\BKSV4-@#L !VK]&\-\)S8VIB']F-OG)_Y(_.?$?%\F$IX=
M?:E?Y)?YLXZBBBOV8_'0HHHH 1@,<] ">F<<5_7A\-=='BCP#H6IB0S#4=.@
MNA)C[X>-6S^M?R(9VC^=?U??L7:__P )5^R'\*M3,GFG4O!^DW6_'^LWV4+;
MOUK\M\38?N\/+SE^G^1^G^&D_P![7AY1_7_,].HHHK\E/UD**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!L@R/QK\>?^#L$
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M+N#<QQN'CBJ/+RRVO*SWMV/E<PXQR_!XB6&K<W-'>RNMD^_F?T 45_/_ /\
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MW?%KQ"D_V>Y70)M.M9 <,D]WBTC88YR'G4\>E?R[=2>.Y)_'_P#4?PK]V_\
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MH?\ ;W_I$CY/C7_D35_^W?\ TN)^/5%%%?T$?@9[Q_P2[_Y2*_!7_L<-._\
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MJ&$I.OB)<L4?3/QH^/'@_P#9Z\$3>(_&_B?1_"VB6WW[O4+E848XSM7)R[$
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M7#F:5EJUIOT:/9RWB#'8"#IX2?*F[O1/7;JF?L'_ ,18G_5!1_X7'_WOH/\
MP=@&3@? 49'/_(\?_<%?CY01D8[&O._U'R7_ )\_^33_ /DCT?\ 77.>M;_R
M6'_R)]:_\%5_^"HO_#S;7_!E^? __"$GPA!=V_E_VU_:?VOSWB;=GR(MN/+Q
M@@]:^2J.E%?0X'!4<'0CAJ"M&.RU?YGS^-QM;%UI8BN[REN]%^05Z3^Q]^T%
M_P ,I_M,^#?B+_9!UX^$M06^&GB[%K]KPI79YA1]O#9SM/2O-J*WK4H582I5
M%=233]&8T:LJ52-2&Z=UZH_8(?\ !U^R88_ 50K 8_XKGGW_ .8?2_\ $6)_
MU04?^%Q_][Z_'S.<^]%?+?ZC9*O^7/\ Y-/_ .2/IO\ 7;.?^?W_ )+#_P"1
M/V#/_!V TH(3X"@''7_A-_\ [W\5]_?\$R/V\V_X**_L]W'CX^%O^$0$&K3Z
M3]A_M/\ M#<8DB?S/,\J+KYN,;>W6OY?@,FOW^_X-EU _P""=-Z<#)\7WW/_
M &[VE?*<8\,Y=@<O]OA:?++F2O>3T^;9]3P?Q)F..S!4,54YH\K>T5^21];?
MMQ?M-G]C;]EGQ9\2QHO_  D0\+013G3OM?V0W6^:.+;YNQ]O,@.=IZ5^9Q_X
M.O'BP3\!A@]O^$XSZ=_L'UK[>_X+=C/_  2S^+G_ %X6G_I?;5_,[GYS_GO6
M'!/#N7YA@YU<73YI*5MY+2R?1HZ.->(,?@,9"EA:G+%QOM%ZW:ZIG["?\18G
M_5!1_P"%Q_\ >^KGA[_@ZJ/B+Q!86 ^!0MQ>7,<+2_\ ":^9Y89@N[;]@&<9
MSC(K\<*U_A_@^/=$!!8'4(,@=QYBY'Y9K["IP1DRBVJ/_DT__DCY&GQKG#DD
MZVG^&/\ \B?UUAV6)69B&.,X.1G/3_(KYY_;@_X*D?";]@334C\9:[+>>))X
MC+;>'M+C%QJ,ZXX+*2%B0G^.1E![$]*\^_X+%?\ !3^'_@GI\$(+70C:7GQ+
M\6JT>B6TJ[H[%%.)+V53U5#PBG[[D#D U_.WX\\<ZQ\3/&&I:_X@U2]UK6]5
MN&N;R^NW+RW,C$DL223W]>.G0"OSWA7@Z68Q^M8IN-+I;>7_  #[_BCC!9?+
MZMAK.IUOLOEW/TZ^+?\ P=-_$+5-4D'@7X:^$=$L0<(=<N;C4IG&?O$1- JG
MV&X#U/6N(T'_ (.=OV@--N6^V:%\+]11R,J^F7<;( 3D+LN\#.0/FSVK\Y1\
MHP.!2EB1U/7/XYK],APCE$(<OL$[=[M_?<_-9\5YM.?,Z\E?MHON/Z,?^"07
M_!6F^_X*7'Q;8:KX,M?"VI>$+>UGDFM=2-S!?"<R ;49%:/:8SU9NO6OMJOQ
MA_X-2O\ DH'QH_[!VE?^CKROV>K\:XJP-#!YG4P^'CRQ7+IZQ3_4_9.%<=6Q
M>64Z^(E>3OKZ-H*9.Q5..I/'.*R_'OCK1_AGX/U#7]?U.ST;1M*A:XO+V[E$
M4-O&HR69CP!7XI?\%*/^#B?Q)\3[R^\(_ N:[\,^&06AF\42(4U+4>H)MUR#
M;1]PQ E; /R#<M<V39#B\SJ<F'CHMY/9?\'R.C.,^PF6T^?$/5[);O\ X'F?
MJG^U3_P43^#W[&=DS>/_ !OINF:CMWQZ3 QNM2E&"01;QAG /3<P5<D9(R*_
M/7X\?\'3^G6,\MK\,OAE=WR*2(]0\2WXMQG_ *]H=Y8=_P#7#Z"OQWUK6KWQ
M)J=Q?:E=7%]>WKF6>XN)C--<.>KNQ))8GN>:K[CZFOU7+?#W+Z$4\3>I+ST7
MR2_5L_+,QX_S"NVL/:G'RU?WO]$?>GCK_@Y'_:7\6S,=.U'P7X74G(73="$F
M!_V\M-Z^W2N-_P"'^/[69))^+# <]/#.C\>G_+I7QYGC':C.3GO7TE/AW+(+
ME6'A\XI_FF_Q/G9\0YG-WE7G_P"!-?D?=7@G_@XP_:>\*31/?^(O#/B98P-R
MZCH%NBR<?Q?9A$1^!%?1/P-_X.H=4AG@@^)7POLKF)R/.OO#.H/"Z#_9MKC=
MO/UG7ZU^1@)!X)%&<Y]ZY<3PEE-=6E0BO\/N_D=&'XKS:B[QKR?K[WYG].W[
M)'_!67X&?MH7%M9>$_&EM9^(;D8&@ZP/L&HEL?<17.R8]_W+/T^M?24+;B.6
M/'4]*_CZAF:"=)$<I(C*RL&P00000?;KVK]!?^"<W_!?SXA_LN7FG^&OB1-J
M/Q$\!92(37,QDUC2(P<9AG;F>,+G$4O/ VR( <_"9UX=SIQ=7+I<W]UVO\GU
M]&?=9+X@PJ-4LPCR_P!Y;?-=/5'] E%<9\!/CSX3_:5^&>F^,/!6N6OB#P_J
MT>^"Z@;[K?Q1NO5)%/#(P!![5V=?FDX2A)PFK-;H_2J=2,XJ<'=/9A39<X')
M'/:G4C=*DI['YQ?\%!_^"_3_ +!G[4FM?#8_"D>+!HUO:S?VE_PE'V#S3/"D
MP'E_9),8#@9W5XI_Q%B?]4%'_A<?_>^OE7_@X3&/^"I/C;_KPTO_ -((*^)J
M_;,EX/RFO@*->K2O*44V^:6[7E)(_%,XXNS6ACJU&E5M&,FDK1VOYIG[!'_@
MZ_,N /@-CGMXYQG/'_/A[U]A_P#!)O\ X*NO_P %/)O'I/@3_A"4\$KI_P#S
M&_[3%Z;K[3G!\B'9L-L1T.=W7BOYNJ_73_@UL\3V'@KPW^T5K6JWEOI^G:7;
MZ#=7=W<.$BMX8UU5W=V/ 50"23T&:X^*.%,LPF65<1AJ5IKEMK)[RBMFWW.W
MACBG,L5F-*ABJMX/FOI%;1;Z)=C]C-?UFT\.Z-<W]_=V]A8V<;37%Q<2K%%!
M&HRS.[<*H ))/05^<7[8/_!R=\+_ ((ZE=Z1\-M+NOBEJUL6B>]BF^Q:.CC(
M.R5E:2;!QG8FQARKU^??_!6__@L+XD_;O\;W_A;PM?WVC?"*PF,=K8HQCDUX
MH2/M-U@Y*L>4B.5 "DC<":^(2[,<DDGZUS\/^'\'!5\RO=_86B7JUJWY:&^?
M\>U%4=#+=$OM=7Z)GWY\3?\ @Y(_:0\;74KZ)=>#O"$&?W2:;HXN&V_[371F
MR?<!>G2N&A_X+[?M9*ZNWQ4#J#DK_P (WH_/MQ:?UKX[/S=>: ,5]U3X<RN"
MY5AX6_PI_BU?\3XB?$.9R=WB)_\ @3_*]C]#OA;_ ,',/[0?@^[A'B"S\#>+
MK)#^^^UZ:UI<2+Z*]O(J*WN8V'7BON3]DC_@Y%^$7QSU"WTGX@6%]\*]7N#M
M6YN[@7NDLW& ;A55H\\G+QA  <N.,_@:!M?<.&]>]"L4<$ E@<C'7U/<5YF/
MX*RK$Q=J?(^\=/PV/2P/&6:X>2O4YUVEK^.Y_7WX8\16?BS1;74M-O;74=/O
M8A-;W5M,LT%PC8*LCJ2K CG(.#GC-:-?S3_\$S?^"M/CW_@GKXS@LENKKQ+\
M-KN<-JGAV:3<L(8C=-:,3^YE ZC.QR?F&<$?T2? #X[^&?VE_A1HOC;P=JD6
MK^'M>M_M%M.G!'."CKU212"K*>5((-?D?$/#6)RFI[_O0>TE^3[,_6>'^),/
MFE/W/=FMX_JNZ.THHHKYP^D/&O\ @H#^U:_[$/[)?BGXH1Z ?$[>&6L_^)8+
MW[$;KS[R"VQYNQ]F/.W?=/W<=Z_-K_B*]V'/_"B X['_ (3D88=C_P >'M[=
M:^QO^"^JAO\ @DO\5\@'!T<CZ_VS8U_-N223GUK]/X*X<R_'X&5;%T^:2FUO
M):6CV:[GYCQIQ#C\!C8T<+4Y8N">R>MY+JGV/V"_XBP1_P!$$7_PN/\ [WTC
M_P#!U^77"? 50W;/C<X/MQI_%?C]1_$/K7V'^HV2_P#/G_R:?_R1\?\ ZZYR
M]ZW_ )+#_P"1/ZUOV</BT_Q[^ ?@?QR;'^RQXS\/V&N_8O.\[[']JMHY_*W[
M5W[?,QNVKG'05VU>.?\ !.U0O[ 'P-P /^+?:!_Z;;>O8Z_!\5!0KSA'9-K\
M3]VPDW.A"<MVD_O04445@= 4V0X&>>/2LWQIXMTSP%X7O=9UG4;/2=)TR)KB
M\O+N988+>)02SN[$!0!W)K\7O^"E7_!QAKOCFYOO!_P$FN=!T(%HI?%TL.V_
MOQ\RDVD;C]Q&><.X$IQG"$$'V,GR/%YE4Y,-'1;R>R]7^AX^;YYA,NI\^(EJ
M]DMW\OU/U+_:C_X*!?"+]C6P5_B#XWTO1KQT+Q:<CFXU"<8)RMO&&?';<0%R
M0">17Y[?'O\ X.G=&L+F:V^&7PSU#5$!(34?$=Z+-,\X(MX@[,IX/,B'V]/Q
MRU_Q'?\ B_6;K4M3O[S4]0NY/-GN;J=YYYG/\3NY+$]>6))JGVK]5RWP]R^C
M%2Q+=27W+[EK][/RO,>/\?6;CATJ<?O?WO\ 0^_/'?\ P<E_M*^+)6.G7/@C
MPLA/RKIVB!R!];F2;/Y"N&E_X+[?M8RL2OQ6VC.<)X:T<X_\E37QX/E''%*S
M%NI)^M?2T^',L@K1P\/G%/\ %GS<^(<SF[RKS_\  FOR/N;P7_P<6_M0>&)X
MWO/$GASQ*B?>34/#UNH?'K]G$1_(BOH7X,_\'4FOV$T,7Q%^%NE:A"3^^N_#
MFHR6CQ+ZK!<"0.?;S5^M?DFQ+#DY^M"DJ<@X(]*Y\1PGE-96E0BO1<OY'3A^
M*LUHN\:TGZOF_.Y_2W^RK_P6C^ /[6U]::=I'B__ (1OQ#<X":1XBC_L^>1C
MT1'),,C=PJ.6(!., U]66TPF 8-N!&>#D8/0@U_'P ""IY4@J1V(QTK^GW_@
MD7?3ZG_P3:^#D]S-+<3/X=CW22N79L.X&2>>@ _"OR_B_A2AE<(5\/-M2=K.
MVFE]_D?I?"/%-?,ZDZ&(BDXJ]UUU2V^9]'T445\*?>!1110 4444 (_W?IS7
MYN_\'0FNG3?V O"]JDBJ]]XZLU9>Y1;&_<D?1@GYU^D,AP!UZ]J_*[_@Z?UG
M[/\ LX_##3LQ8N_$D]R0?OGR[5EX]OWO/N17T/"<.;.*"7?\DV?.\63Y<IKW
M[?JC\1AG:,C YQST]OY448Y)[GJ:*_HI*Q_/)[5_P3>TM]8_X*"_!"&,H&7Q
MUHLWS=,1WT,A_137[L_\%WO@U_PN3_@F=X[\F S7GA;[-XBM1M!V"WE F;VQ
M;//GVS7XF?\ !(/1?[?_ ."F'P;@\KS?+\0QW./3R4>7/X;,U_2O\6?AU9?%
MSX6^)/"NI*K6'B?2KG2;D, P,<\31."#UX:OR?CO&/#YOA:R^PD__)O\D?JO
M ^#6(RG$TG]MM?\ DO\ FS^1:,@C@8SC^5.J_P"*O#%YX*\4:EH^H1-!?Z3=
M2V5S&PP8Y8G*.I^A!JA7ZO!W5T?EDDU)IC[:ZDL;F.>)WBDA8.KHVUD(Y!!'
M0@]#7]9?[+OQ:C^//[.W@;QHC(3XJT&RU1PARJ/+"CNGU5RP_"OY,=I=@  3
MGH:_HE_X-W?C)_PM7_@FMH&GRR>;=^"=3O-"D8GYBH<7,7'8"*YC7_@%?G/B
M3A.?!TL0OLRM\I+_ #2/T/PYQ7)C*E!_:C?YI_Y-GW/7&?M%?%.#X&_ 7QEX
MTNMOV?PGHMYJ\@)QN$$#R;?J=N![D5V3?KVYKXG_ .#@?XPK\*?^"9/BZU2;
MR;SQE>V7A^W.?O>9,)IA^-O!,/QK\IRS"?6<72P_\TDOQU/U3-,5]7P=6O\
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M0]1]:6D/4?6OT%GY^C^JO_@G=_RC_P#@9_V3[0/_ $VV]>Q5X[_P3N_Y1_\
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M3SC_ .M_("OUSPWP"C1JXR6[?*O16_5GY'XCXYRK4\''9+F?J_\ @("<FE&
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MZII/\&?F?B/@H.C2Q:6J?*_1JZ_(^2J-N\A?[Q HI5.T],_@37[ ?D9^U/\
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M^_V6;;]G_P#8$T77;FT2/Q#\2W/B"^D9/G\ALI:QYZ[!" X'0&9R/O'/W*%
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MR>,O^_Z?_$4?\/@/VF?^BR>,O^_Z?_$5\UX'H*,#T%1_9."_Y\Q_\!7^1?\
M:V-_Y_2_\"?^9]*?\/@/VF?^BR>,O^_Z?_$4?\/@/VF?^BR>,O\ O^G_ ,17
MS7@>@HP/04?V3@O^?,?_  %?Y!_:V-_Y_2_\"?\ F?1]]_P5U_:4U"REMY_C
M'XO>"X1HI$:= '5@01]S/?MS7SAGY\'&>>1QWYXP,48&",#!I?7WYKHH82C1
MO[&"C?LDOR.>OBZU:WMIN5N[;_,*,9(]<C\>:*"=JEO[O/3-=)SG]2__  32
MU>76?^">?P0GE_U@\%:3"3G[WEVD:9_$+FOR<_X.DO$+W7[9W@+2CGR[+P5%
M=@9X!FOKQ3_Z(%?K+_P3;T9M _X)\_!*WD+,_P#PA.CRX(QM\RTB?&/;<1^%
M?D?_ ,'1EA+%^W;X,NBF()_ 5I$K9ZLFH:B6'_CZ_G7XCP?&/^L4K=YV/VGB
MV4O]7XI]H7/S6HHHK]N/Q8^BO^"2/@^+QQ_P4I^#-E*@D6'Q)!?@$@ -;!KD
M'GWB%?T_Q<X.,<?6OYE/^",6M1:#_P %/O@_/-]Q]7>V'./FEMIHE_\ 'G%?
MTUQ#';%?C'B5?Z]23_D_5G['X<)?4:K6_/\ HA]%%%?G1^BA1110 UR  3V/
MI7YL_P#!T#X0BU7]A'PMJX5!<Z-XSM\.1SY4MI=AE'U98_\ OD5^DTG0=.OK
MBOSI_P"#G/4(+3_@G;I$,K$/>>-+&&+_ &G%K>OC\E/->]PNVLVH.._,>#Q0
MD\JKI_RGX%LVYSQC'2BAR3*21MSSUSGFBOZ./YU6Q[Q_P2[_ .4BOP5_['#3
MO_1Z5_4C']XU_+=_P2[_ .4BOP5_['#3O_1Z5_4C']XU^->)?^^T?\'_ +<?
ML'AO_NE7_&O_ $D?2/T'U%+2/T'U%?G!^CL_&#_@ZR_Y*!\%_P#L'ZM_Z,M:
M_).OUL_X.LO^2@?!?_L'ZM_Z,M:_).OZ$X+_ .1-0]'_ .E,_G[C'_D<5O5?
M^DH*^D?^"/\ _P I,_@U_P!C G_HN2OFZOI'_@C_ /\ *3/X-?\ 8P)_Z+DK
MU\X_W"M_@E^3/)RG_?J/^./YH_IZ7[Q_SZTM(OWC_GUI:_F-'],!1113 ^5/
M^"W?_*+/XN?]>%I_Z7VU?S._\M#_ )[U_3%_P6[_ .46?Q<_Z\+3_P!+[:OY
MG?\ EH?\]Z_:/#?_ )%]3_'_ .VQ/QGQ'_W^G_@_5BTJD[@!P3Q]*2CO^E?H
M;/ST_JN_X)_^'4\)_L,_!S3TVG[+X)T=7('WG^Q1%S^+9/XUZ]7F?[%O_)GW
MPI_[$[2/_2&&O3*_EW&N^(J-_P S_,_I[ JV&II?RK\@ILOW>I!]OI3J1S@?
M_7KF.IGYA?\ !TMXG-G^R!\/]&$A U#Q>MV4_OB&SN5Y/IF8<5^&)Y.>]?MW
M_P '3FDR2_LV?#*]&TPV_B::!^>0TEK(P]ND9K\1*_>. 4O['@UWE^9^$<=M
M_P!KS3Z*/Y!3[:VDO+J.*)#)+*P5$ )+,> /Q.*95SP]JK:%X@L+Y4\PV5Q'
M/MW!=VU@V,]NE?93=HMGR$=T?US?#OPC;> / VBZ%9@+::+806$ "[<)%&J+
MQ]%%;55]-F2YMHI8V5TD0.K*00P/((JQ7\K2;;;EN?U'3244D%%%%(L****
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M97YMU^DO_!KE_P G_P#C#_LGU[_Z<M,K'BO_ )%%?_"='"O_ "-J'^(_>8*
M<@#-+117\YG]$A1110 C ,,$9K^>3_@XZ 7_ (*9ZI@8SX>TW/\ WPU?T.'I
M7\\?_!QW_P I,]4_[%[3?_0&K[KP\_Y&K_P2_.)\)XA?\BQ?XE^3/@^@C-%%
M?N1^)'Z2_P#!KD3_ ,-_>,.?^:?7G_IQTROWGK\&/^#7+_D__P 8?]D^O?\
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M@)QUP,X'>OVUL_%C[V\/_M5&V_X-Z/$7@-YD^U/\1X- BCW_ #K:2!=5#X[
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MN?>;/>OR;PWQ2IX^="7VXZ>JU_*Y^J>(F%<\#"M'[$M?1Z?G8^ Z#GL&)[
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M_P#$2,P_Y]P_\F_S/H?^(<X#_GY/_P E_P C^9W_ (<B_M4?]$AUC_P/L?\
MY(H_X<B_M4?]$AUC_P #['_Y(K^F+ ]!1@>@H_XB1F'_ #[A_P"3?YA_Q#G
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M +)]>_\ IRTRL>*_^117_P )T<*_\C:A_B/WGHHHK^<S^B0HHHH #TK^>/\
MX.._^4F>J?\ 8O:;_P"@-7]#AZ5_/'_P<=_\I,]4_P"Q>TW_ - :ONO#S_D:
MO_!+\XGPGB%_R+%_B7Y,^#Z***_<C\2/TE_X-<O^3_\ QA_V3Z]_].6F5^\]
M?@Q_P:Y?\G_^,/\ LGU[_P"G+3*_>>OPGC__ )&\O\,3]SX!_P"12O\ %(^/
M/^"^G_*)?XL?]PC_ -/-C7\VW<_6OZ2?^"^G_*)?XL?]PC_T\V-?S;=S]:^U
M\./^19/_ *^/_P!)@?&>(O\ R,H?]>U_Z5,*0]1]:6D/4?6OT%GY^C^JO_@G
M=_RC_P#@9_V3[0/_ $VV]>Q5X[_P3N_Y1_\ P,_[)]H'_IMMZ]BK^7<=_O-3
M_$_S/Z=P'^[4_P#"OR/A7_@XL^&1\>_\$R-?U".#SG\'ZSI^M!0N6 \PVK,/
M3"73$^P-?SN#.!Z'./S_ /UU_6E^T[\%K/\ :,_9[\9^!+XHEMXLT>ZTPR,H
M;R&DB94E ]4<JX]"H-?R>^*?"^H>"/$^HZ-JUK)9:II-S)9WEO(NUH)HW:-T
M(]F4C\,]Z_6?#?&J>$J89O6,K_)V_5'Y/XC8-QQ=/$I:2C;YK_@,H4$C(!SS
MZ?G_ "HI5X(.<8(./[W/3\:_2&?G:W/Z?_\ @DW\?(?VCO\ @GW\,-?6<3WM
MKHL6C:@=^YOM=F/LLI;N"QB#\]1(#7T97X3?\&Z?_!0NW^ WQ9U#X0>*;\6O
MAWQY<+<Z//(^(K/5 H4QY)P%N$ 4,?XXHUZ-7[JPOO8YR/3G(//^?SK^=.*,
MJG@,PJ4VO=DVXONGK^&Q_0_#&:PQ^ A43]Z*2DNS7^9)1117SY] %%%% !11
M10 4444 %%%% !1110 R<X3CKV]^*_EN_P""H.O_ /"2?\%%/C7<>:9?*\8Z
MC:YZ8\F=XL?ALQ^%?U(W'^K/8=Z_E _;/UT^*?VQ/BQJGF"4:GXQU>Z#8QN#
MWT[9_6OTKPTA?%5I=HK\S\V\29_[+1A_>?Y'FM(PR*6C./?GIZU^Q/S/R _;
M3_@U7T(6WP(^*VH^45>ZUVSMB^<AO+MB^/J/.Y^M?JQ7YG_\&MFE);_L.^-[
MP%O,N/'-Q"01A<)I]B<C\78?A7Z85_.W%L^;-Z[\U^"2/Z%X2ARY107D_P 6
MV(X)'&,^]?F/_P '07P4_P"$N_9$\&^-X8=]SX,\0_99&Q_JK6]B*N2>W[Z&
MV'XU^G) (YYKY^_X*I_!C_A?7_!/'XM>'DA,]W_8$VIV<:KEI+BSQ=Q*/=G@
M5?HQKCR#%_5<QHUV]%)7]'H_P.O/\)]9RZM12U<7;U6J/Y=,')SV/8<<_P#U
M\T=_I2 ?,2!CZ]?\_P"-+7]*+8_G!^0 8HHHIB '!^E?T4?\&\?P8'PH_P""
M:GAW4983#>^.=2O=?G#+@[6D^SQ?@8K>-A_O5_.]I>GSZOJ=M:6L+W%U=2+#
M#$HRTKL=JJ/<DXK^M']G/X46_P "/@+X+\%6N##X3T.RTA6 QYGD0)&7^K%2
M2>Y)-?FWB3C.3"T\,OM2N_2/_!?X'Z-X<X3GQ=3$/[,;?.7_  $=I39!D#ZT
MZF3 D#'K7XX?L1^+G_!U;HJP?$OX-:B%<-<Z9JEL6/W2(Y;9@/J/-.?J*_)F
MOV/_ .#K72A/X?\ @A?[FS!<ZU %V\$2+8MDGU_=_P Z_'"OZ!X)GS9-1\N9
M?=)GX!QI#ESBMY\K_P#)4%>L_L$:Q_PC_P"W-\&;XLZI:>.=%D?8<$J+^'</
MQ&1]#7DU=5\"M>_X1;XV^#M3W2)_9VN65SNC8JZ[+B-LJ1R",5]'BX<]"<.Z
M?Y'SN%GR5H2[-?F?UN !A@]#USUKX6_X. ?V+I?VI?V++CQ!HUF;OQ5\,9GU
MNUBC7=-<694"\A7O]Q4EP.6-LJ]Z^ZXE[G!.*2Z0-#@HKCIM/0]L?2OYFR['
M5,'B(8FEO%W_ .!]VA_2>88&GC,-/#U-I*W_  ?O/X]U'R]^,?RS2@D'(X-?
M=_\ P6[_ ."6MY^Q1\8)_&OA/3I3\+?&-TTMMY2?)X>NV)9[.3'2,G)B/3;E
M>JEF^#P-IQU!R<D'/^'%?TGEV84<;AXXF@[QE^'D_,_G3,<OK8/$2P]=6DOQ
M\T.0[> !C!&,9_+_ #QUK]8_^"4G_!P1#\+/#>F_#SX[SZC=:=8JL&F^+HPU
MS-!'P%2\C4;Y$4# EC#L, %<?,OY-TBJ%Z #Z5AF^387,J/L,5&ZZ-:-/R9M
ME.<8G+JWML,[/JMT_4_KD^%7QB\+?&WPI;:[X1\1:1XETB[4-'=Z;=I<Q'C.
MW*DX8=U.&]173H<GJ?7KUK^1KX7_ !E\7_!+7?[4\&>*?$/A34L8-SI&H2V<
MK#(X)C(R.!P>*^F_A[_P7E_:C\ Q1P#XDR:Q @XCU72K*Y/U,C1"0GZL>IK\
MQQ?AMBHR;PU527]ZZ?X)H_2L'XCX:45]9I-/^[9K\;,_I,HK^?33O^#EO]I*
MRLQ'+%\/;MUS^]ET616;Z[)POOT[5S_B/_@XE_:AUVW\NV\6:#I+8(+VGAZU
M+<_]=5<#%<$?#W-&]7!?-_\ R)Z$O$+*TM%/[E_F?T4R':!]>:\E_:%_;C^$
MG[*EC+/X]^(?AKP])"H8V<MV);UAZK;1[IF_!#7\X?Q9_P""FO[07QPAGA\2
M?%[QO=VMP-DUM::DUA:RCT:&V$<9'L0:\.FN)+F9I)'>21FW%F)))]<^M>S@
M_#23=\56LNT5^K_R/%QOB0K6PM'YR?Z+_,_8G]L;_@Y]MK>.YTCX)>%9992&
M0>(/$L9CC0X(#0VBG<_J#*ZXQS&1T[#_ (-M?VD?'G[3OC7X_P"O^/\ Q5K7
MBK5G.@,)+Z?,=ON_M+*Q1 !(E(5>$55^48SBOQ#!([GUK]AO^#3L8'Q['H/#
MW_N4KT^(N'\#E^25EAJ:3]W5ZOXH]7^AYO#V?X[,,ZH_69MKWM%HOAET7ZG[
M#$ ]1FN=^+?PXTKXO?#'7O"NN6PN]&\1V$VFWL/ ,D,J%' /9L,<'L<5T5-F
M^Y@'&>_>OQJ,G%J479H_8YQ4HN,E=,_DL_:3^ ^L?LP_'?Q3X U^-TU7PKJ$
MMA(Y4JMRBL?+F7/5)(RCJ?[K#OFN(K]P?^#B7_@FU<_&?P+%\;?!NG>=XD\)
M6@M_$-K"I+W^G(25G"C[SP%FW=VB/_3-17X?9VJ!G/ ZXR/8^XS@^N*_HSAS
M.J>98.-9/WEI)=G_ ,'<_G;B')JF78R5%KW7K%]U_P #8" PY&:]7_8P_;)\
M9?L+_'*P\<^"[M8[J(>1?64V3:ZK;,P+P3 =5) (/!5@"""!7E% .#7LUZ%.
MM3=*JKQ>C3/(H5ZE&HJM)VDM4S^GS]A/_@IY\+OV^?"$$_A;6XM.\3Q0AM0\
M,ZA,L>I6#CAL*3^^CSC$B9'S*&V-E1]&Q/O'0CZU_'[I>J76AWT%W8W-S9W5
MHPDAFMW9)(&'1E92"I'J.:^FOA7_ ,%H_P!IOX0Z='::7\6]?O;:%=NS6+>V
MU5L=AONHWD'X&ORK,O#>7/S8&HK/I+I\U>_W'ZAEGB+'DY<=3;:ZQZ_)VM]Y
M_32YQCKR>U<]\2/BCX?^#_@Z]U_Q3KFE^'M%T^,O<7NHW*V\$8QW=B!GT Y/
M:OYX?$/_  7Y_:K\169@'Q'@T]&&&:S\/Z<C'C^\T!*_48-?,WQF_:,\>?M&
M:^-3\=>,?$7BZ]0_NGU._>X6 >D:D[4'LH KEPOAOBI37UFK%+^[=O\ %(ZL
M7XC8:,/]FI2;_O62_!L^\?\ @LG_ ,%O)?VN--N_AG\+)[RP^'+/LU75'7RK
MCQ&5/$:J3F.VXZ-\TG!PH&#^;FXD<D9;D>_)/Y9- )!."1FKFA>'[_Q/J/V3
M3;*[U"Z:-Y?)MXFD<I&C.QP.<*JL<^U?J.697ALMPZHT%9+=OJ^[?<_,<RS/
M$YA7=:N[M[)=/)>13HI$8.BE3N7^]Z\"EKTT[JYYIW_[*?Q;C^ ?[37P_P#&
M\X<VOA/Q#8ZK<J@!9H8KA'D49[E P^IXYK^KCP;XMTWQYX9T_6M(O;?4=*U:
MVCO+*Z@</'<PNH9)%8=5*D$'WK^0CGJ%+$>F,CM7N?[-7_!2GXZ?LC>'O['^
M'WQ&UG1-&5B8]-EC@O[.V8DLWEQ7"2*F6)8A5&22>_/Q7%W"T\U<*E"24XW6
MNS7RN_P/L^$^*(95STZT6X2L]+73^=C^IFFRX*X/()K\4O\ @CQ_P5.^/W[6
MW_!0?P?X3\?_ !"N]<\.75IJ$TEFFEV-BDK1VDKJ6\B&,G!&1DD<9QD C]JX
M3OZYR /PK\?SO)JV65UAJ[3DTGI>VM^Z78_7<ESJCF=!XB@FDG;6U]+=F^Y^
M3?\ P=5> );[X2?"'Q4%D:WT?5K_ $N1QT#74,4B@C_MS:OQ:4$8R.W7/6OZ
M7O\ @M=^S)/^U)_P3L\;Z5IUL+G7/#B)XDTQ ,LTMKEI%4#DL]N9T '=Q7\T
M7&<!0,#.?KV_+'ZU^N>'V,C4RSV-]8-K[W=?K]Q^3\?8-TLR]K;2:3^[1_I]
MX5J>"/&FH_#CQGI'B#2)VM=5T*]AU&RF4X,,\+B2-@>Q#*#^%9='?Z<U]Q.*
ME%Q>S/B82<9*2W1_4Q^P1^W/X2_;S^!FE^+O#=W FH&)8M9TEI0;K1[O'SQ.
MN<[3@E'QAUP1W%>XIR^=Q/&,9X^M?R.?";XR>+O@5XOCU_P5XDUOPMK<2E5O
M-+O9+69E)!*,4(W*<#*ME3@9' KZE\._\%_?VJ/#FGBU;XB6^H*F K7>@Z>\
MH&, ;Q ,GW.:_(LQ\.,0JKG@IKD;T4KIKRT3/UK+?$2A[)1QL'SI:N-M?O:/
MZ0'.%SSQZ4V,Y8\DXXZU_-1XW_X+E_M2^/[2>WN/BQ?V$$HQMTS3;"RD0'TD
MB@60'KR&[U^M/_!N]\4_%'QB_80U'6O%WB+7/%&KOXLOHC?:M?RWMP4$-L0F
M^4E@H+-A<X&3ZU\_G'!^*R["?6J\XO5*RN]_5(]_*.+\-F.*^JT(26C=W;IZ
M-GHW_!;O_E%G\7/^O"T_]+[:OYG?^6A_SWK^F+_@MW_RBS^+G_7A:?\ I?;5
M_,[_ ,M#_GO7W?AO_P B^I_C_P#;8GPWB/\ [_3_ ,'ZL6CN/K11W'UK]$9^
M>,_K _8M_P"3/OA3_P!B=H__ *0PUZ97F?[%O_)GWPI_[$[1_P#TAAKTROY;
MQ?\ 'G_B?YG]08+_ '>G_A7Y!1117.=(R=-Z8YZ]CBOP!_X.)/V&Y?V>?VK3
M\1]&LA'X2^*#O=SNBD16>K YN4..GF\3 GJSS?W17] )&:\H_;3_ &2_#/[:
MO[.NO_#[Q/%LL]7CW6UY&@,VF72@^5<QY_B0]><,I93PQKW^&LY>68Z->7P/
M27I_P-SP.),F698)T8_$M8^O_!V/Y22,.1GN1CNI[BG!BO0D5Z%^U3^R_P"+
M?V._CAK'@+QI8FSUG2GW"1 3;7T+']W<0L?O1NH!'<<AL,"!YY7]$TJL*L%4
MINZ>J:/YZK4ITING45FMT6]!UR]\,:W::CIMW=6&H6,Z7%M=6S%9K>5&#)(A
M!!#*P##!'(ZCDU^W'_!+O_@X.\+_ !3T/3O!GQPU"V\*^+;>-;>W\12CR]-U
MGL#,P $$QZDD+&W)!7(6OP[(#=0#3MQ!)R<D8/N*\C.L@PF9TO9XA:K9K=?\
M#R/7R;/L5EM3GH/1[I[/U_S/Z_/#^OV?B;3+>^T^\M;^RNXQ+!<6\HEBF0XP
MRLI(8'U%7FZ=<5_)K\&/VLOB=^SFV? GC[QAX4B+!GM]+U2:"WE/^W$&V-_P
M)37LT7_!;/\ :G@A5/\ A;^N,%&!FQL6/XGR,GZYS7YM6\-L6I-4:L6O--/\
M$T?HM#Q(PKBO;4I)^5FOS3/Z8+B<0J&)P.O?IZU\)_\ !1K_ (+K?#7]C[0M
M1T3P=>6'Q#^(RAX(;*RN/,T_39>06NID.W*$C,*'>2-K&/.X?A]\:?V[OC/^
MT+936GC3XF>-M<T^XXEL)]4E2RD^MNA6/_QVO)1Q^6*]7*_#BG":GCZG,E]E
M*R^;>OW)'EYIXB5*D'# PY;]7J_DEI]]SJ?C5\9?$W[0GQ1UCQIXPU>XUSQ'
MKT_VB[O9CRY "J% X1%4!54  *HV@#@<MTHQS17Z93IQIP4(*R6Q^;5*DIR<
MYN[8'Z$GTKZL_P"".?[#LO[</[9FAZ=?6;S>#/"CKK/B)WCS%)!$RF.V)Z$S
M2!5(Z[#(>U?./PO^%VO?&KX@Z1X4\,:9=:SK^O726=C9VX^>:5F  ST51U9F
M(55!)( R/Z6?^"7?_!/G1_\ @GI^SC:^&8_LVH>*]5VWOB75(X\"^NB/N(2
M?)B!9$!QU9L N:^1XQX@CE^$=.F_WL]%Y+J_ET/J^$,@EF&+52:_=PU?GV1]
M'VQ&XX&,C./3\.W6ICTI%14)P ,]<#K2GI7X(?O/0_G,_P"#A/\ Y2D^-O\
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M'_!+K]HL'GX*_$=?<:'/_P#$U^H_VGA/^?T/_ D?F']G8O\ Y]2_\!9^QO\
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M_$FDV&M:%K,)M[VQNXA)#<1D=&!]."",$$ @@BO$X>SZKE6*]M!7B])+NO\
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MF_#.!Q,,TH2G3DDI=8L_9RBBBOY_/WX****  ]*_GC_X.._^4F>J?]B]IO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
